Agomab Therapeutics NV (AGMB)
Market Open
12 Jun, 13:49
NASDAQ (NMS) NASDAQ (NMS) Primary $
9. 84
-0.04
-0.4049%
$
488.54M Market Cap
- P/E Ratio
- Div Yield
8,858 Volume
- Eps
$ 9.88
Previous Close Investors:
Want to track AGMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Agomab Therapeutics NV (AGMB) Statistics
Valuation metrics
Market Cap 488.54M
Enterprise value 423.94M
Trailing P/E (ttm) -6.74
Forward P/E -
PEG ratio -0.07
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA -9.24
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 67.51K
Average volume (90 days) 143.06K
Price summary
52-Week low 8.75
52-Week high 17.45
Beta -
50-Day moving average 11.18
200-Day moving average 12.59
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -
Return on equity -
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.28
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) -
Book value per share (mrq) -
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
